ZHENLONG is a leading global biopharmaceutical company dedicated to enhancing human life through the integration of science, technology, and talent. By partering with Jiangsu Lianhuan Pharmaceuticals, our vision is to improve the quality of life through innovative medical solutions.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in December 1999.

Successfully listed on the main board of Shanghai Stock Exchange in March 2003.

The stock is referred to as “Lianhuan Pharma” and the stock code is 600513.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. has grown into a national high-tech enterprise integrating R&D, manufacturing and marketing, and its products involve organic intermediates, chemical APIs and chemical finished pharmaceutical dosage forms. The company's annual revenue exceeds RMB 2 billion.

Lianhuan Pharma has formed two R&D platforms in Nanjing and Yangzhou based on academician workstation and doctor workstation, and has established good technical cooperation relations with Shanghai Institute of Pharmaceutical Research of Chinese Academy of Sciences and China Pharmaceutical University, etc.

The company's product portfolio encompasses five major therapeutic categories:

1. Urological System

2. Antihistamines

3. Cardiovascular

4. Steroid Hormones

5. Antibiotic

Fully utilize system platforms such as SCADA and MES for intelligent analysis and control, elevating workshop intelligence levels

Our customer base spans across Southeast Asia, Africa, South America, and the Middle East.